亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The global burden of heterogeneity of lupus erythematosus interventional trials

医学 临床试验 随机对照试验 心理干预 干预(咨询) 内科学 精神科
作者
Jingru Tian,Hang Zhou,Dorthy Fang,Ping Yi,Pengpeng Cao,Juan Liu,Feng Xiong,Bo Zhang,Yi Liu,George C. Tsokos,Qianjin Lu
出处
期刊:Journal of Autoimmunity [Elsevier BV]
卷期号:128: 102798-102798 被引量:3
标识
DOI:10.1016/j.jaut.2022.102798
摘要

To explore bias in lupus erythematosus (LE) randomized clinical trials (RCTs) and to help the development of benchmarks for future trials and management. We searched systematically three databases and three registries to summarize the interventional randomized clinical trials (RCTs) and identify factors associated with participant loss. Trials which examined pharmacological interventions with control group were included and a meta-analysis was carried out by using fixed and random effects models to calculate risk ratio of participant loss in the intervention and control groups. A total of 481 trials with 68,582 participants met our inclusion criteria, organ specific interventional studies along with trials that address quality of life attributes and geopolitical disparities are missing or lagging behind. 90 trials were involved in the meta-analyses, the withdrawal ratio between intervention and control groups was distinctly influenced by national income of the trial-conducted country. In high income countries, the withdrawal ratio was relatively constant, while for trials conducted in low and middle income countries, the results were altered by trial registration, year of start, number of centers, number of participants, and primary outcome identification. Moreover, the comparability of participants was also worrying, trial location and registration status altered basal participant adherence. Our study reveals the unexpectedly huge heterogeneity brought by national income and trial registration in lupus RCTs worldwide. To maintain the fundamental repeatability and referenceability of LE RCTs, rigorously designed single-country trials with diverse inclusion criteria are needed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.2的应助被闪闪婴采纳,获得30
7秒前
11秒前
17秒前
舒心魂幽发布了新的文献求助10
21秒前
AN完成签到,获得积分0
29秒前
38秒前
urtey发布了新的文献求助10
38秒前
无极微光的应助被舒心魂幽采纳,获得20
39秒前
40秒前
饱满乐安完成签到,获得积分10
41秒前
45秒前
46秒前
舒心魂幽完成签到,获得积分10
57秒前
orixero的应助被mengran采纳,获得10
1分钟前
1分钟前
落后的雪青完成签到,获得积分10
1分钟前
隐形骁完成签到,获得积分10
1分钟前
urtey发布了新的文献求助10
1分钟前
陆上飞完成签到,获得积分10
1分钟前
urtey发布了新的文献求助10
1分钟前
xin完成签到,获得积分10
1分钟前
xin发布了新的文献求助10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
小穆的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
1分钟前
秋风的应助被科研通管家采纳,获得10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
v0id的应助被科研通管家采纳,获得10
2分钟前
6666的应助被科研通管家采纳,获得30
2分钟前
秋风的应助被科研通管家采纳,获得10
2分钟前
2分钟前
urtey发布了新的文献求助10
2分钟前
无奈奎完成签到,获得积分10
2分钟前
小小沙发布了新的文献求助10
2分钟前
小小沙完成签到,获得积分10
2分钟前
2分钟前
2分钟前
HThree完成签到 ,获得积分10
2分钟前
天真的紫安完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158739
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719214
捐赠科研通 7748281
什么是DOI,文献DOI怎么找? 3427072
关于科研通互助平台的介绍 2551964
邀请新用户注册赠送积分活动 2471326